Reaction
Balanoposthitis reporting signals
As of the last recalculation, Balanoposthitis appears in 792 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is CANAGLIFLOZIN (PRR 91.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canagliflozin | 92 | 91.3 | 91.6 |
| Dapagliflozin | 73 | 67.1 | 67.2 |
| Empagliflozin | 102 | 45.6 | 45.6 |
| Panitumumab | 10 | 17.0 | 17.0 |
| Eplerenone | 8 | 16.6 | 16.6 |
| Travoprost | 3 | 9.1 | 9.1 |
| Polatuzumab Vedotin | 3 | 8.1 | 8.1 |
| Lifitegrast | 3 | 4.8 | 4.8 |